Tag: pharmaceutical industry
Blog Posts (16)
April 29, 2013
Doctors Blast Ethics of $100,000 Cancer Drugs
[CNNMoney] Should a life-saving drug that can be profitably sold for far less cost more than $100,000 per year? A group of more than 120 cancer researchers and physicians took the unusual step this week of publishing a research paper taking aim at phar...April 18, 2013
FDA’s Rejection Of Generic OxyContin May Have Side Effects
[NPR] Banning cheaper, generic forms of a dangerous drug sounds like a worthy idea. But the Food and Drug Administration’s decision to bar generic OxyContin may also push patients towards less effective drugs without eliminating the risk of addic...April 18, 2013
FDA’s Rejection Of Generic OxyContin May Have Side Effects
[NPR] Banning cheaper, generic forms of a dangerous drug sounds like a worthy idea. But the Food and Drug Administration’s decision to bar generic OxyContin may also push patients towards less effective drugs without eliminating the risk of addic...April 8, 2013
Orphan Drug Prices Under Siege in Austerity-Minded Europe
“They’ve started looking at how much money…these companies are making… If you make more than a billion dollars out of a product…somebody’s going to wake up and say… you’ve recouped your R&D…you’ve made an...April 3, 2013
Diagnosis: Human
[Ted Gup, NYTimes] THE news that 11 percent of school-age children now receive a diagnosis of attention deficit hyperactivity disorder — some 6.4 million — gave me a chill. My son David was one of those who received that diagnosis. In his case, he...March 26, 2013
Supreme Court weighs deals to delay generic drugs
[Los Angeles Times] A government attorney urged the Supreme Court to allow authorities to crack down on cash deals among prescription drug makers that delay the introduction of generic drugs and keep consumer prices high. The so-called pay-for-delay de...March 22, 2013
CRO with a scandal-plagued past shuts down, leaving patients stranded
[FierceBiotech | By John Carroll] PRACS Institute, the CRO that attempted to rise Phoenix-like from the ashes of scandal-plagued Cetero Research, has reportedly slammed its doors shut, laying off hundreds of workers with virtually no notice and l...February 28, 2013
Testing Drugs on the Developing World
[The Atlantic] For people struggling to put food on the table and a roof over their heads, “voluntary” participation in clinical trials is a slippery slope. While disclosure of new data from pharmaceutical companies is a good first step, qu...February 23, 2013
Kentucky Attorney General Sues GlaxoSmithKline
[PharmaPro] LOUISVILLE, Ky. (AP) — Kentucky’s attorney general has joined in the flurry of legal action against GlaxoSmithKline, filing a lawsuit accusing the company of concealing the cardiovascular risks associated with a diabetes drug. The s...February 15, 2013
Report: Action Needed To Wipe Out Fake And Substandard Drugs
[NPR] A blue-ribbon panel is urging stronger regulation of pharmaceuticals around the world to combat the growing problem of fake and poor-quality medicines. The quality problems and fake medicines have affected Americans. Fungal contamination of stero...Published Articles (2)
American Journal of Bioethics: Volume 8 Issue 8 - Aug 2008
Conflicts of Interest in Bioethics: A Response to Our Critics David C. Landy
American Journal of Bioethics: Volume 8 Issue 8 - Aug 2008
Who Is Buying Bioethics Research? Richard R. Sharp
News (7)
June 21, 2012 1:12 pm
Health Groups Criticize Allergy Drug Promotion (New York Times)
Public health advocates on Wednesday accused the drug company Merck of improperly marketing an over-the-counter allergy medicine directly to children using animated characters from the movie “Madagascar 3: Europe’s Most Wanted.”
June 9, 2012 9:18 pm
Obama Was Pushed by Drug Industry, E-Mails Suggest (New York Times)
After weeks of talks, drug industry lobbyists were growing nervous. To cut a deal with the White House on overhauling health care, they needed to be sure that President Obama would stop a proposal intended to bring down medicine prices.
May 9, 2012 10:15 am
Senate Inquiry Into Painkiller Makers’ Ties (New York Times)
Two senior senators said on Tuesday that they had opened an investigation into financial ties between producers of prescription painkillers and pain experts, patient advocacy groups and organizations that set guidelines on how doctors use the drugs.
May 4, 2012 1:35 pm
FDA recommended to continue monitoring drugs' safety after approval (News-Medical)
The FDA-which asked the IOM to “convene a committee to evaluate the scientific and ethical issues involved in conducting studies of the safety of approved drugs”-already collects much of the suggested information, but the data are scattered across multiple records rather than amassed in one central location. “Decentralized records make it difficult for physicians, policy makers and consumers to easily assess information about risks and benefits that accrue over time,” Faden notes.
May 2, 2012 3:38 pm
China, Bioethics & The Wild West: Joe Explains (Pharmalot)
Next fall, the University of Pennsylvania will host a 10-day crash course in Bioethics in China, which some may argue is an oxymoron. The program will actually take place in Beijing and other cities, and include meetings with academics, policy makers and pharma folks, such as expats who work for large drugmakers. The plan is to not only review some of the hot-button issues – corruption, clinical trials, intellectual property and interactions between physicians and patients – but also delve into cultural differences that shape the way business is done there.
April 25, 2012 11:38 am
Drugs firm takes cost conscious doctors to court (The Independent)
Independent experts have condemned the Swiss pharmaceuticals company Novartis for trying to force the NHS to buy an expensive drug to treat patients suffering from a degenerative eye disease, rather than using a cheaper, unlicensed alternative. Novartis is taking four NHS areas in the south of England to a judicial review because they have allowed doctors to prescribe the anti-cancer drug Avastin to treat the wet form of age-related macular degeneration.
April 24, 2012 11:23 am
Dying Mom Posts Video for Compassionate Use; Company Agrees (ABC News)
Social media proved to be one powerful tool for a mother dying of breast cancer and desperate to get a drug that has yet to be approved by the U.S. Food and Drug Administration… Gant, 46, posted the video on YouTube as an attempt to plead with the FDA to allow her to use a trial drug known as pertuzumab under compassionate use. The FDA is expected to approve the drug, developed by Genentech, on June 8. But Gant doesn’t expect to live that long.